Rwanda

7 Vaccines Approved for Use in Rwanda

RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: theeastafrican.co.ke
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: rbc.gov.rw
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: rbc.gov.rw
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: theeastafrican.co.ke
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: rbc.gov.rw
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: rbc.gov.rw

4 in Clinical Trials in Rwanda

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
DNA

Inovio

INO-4800

10 trials in 9 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries